Coronary Sinus Reducer an Option for Intractable Angina?
A coronary sinus reducer met one of two primary endpoints by reducing refractory angina in the ORBITA-COSMIC trial, but not the second, improvement in perfusion.
Source: medscape.com
Stay updated with breaking news from None Measure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A coronary sinus reducer met one of two primary endpoints by reducing refractory angina in the ORBITA-COSMIC trial, but not the second, improvement in perfusion.
World’s five largest container liners — with 65% of global capacity — have suspended transits through the Red Sea. This means higher shipping costs and longer delivery timelines. How will this affect inflation in Europe?